• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORCYM CANADA CORP. PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVF-M
Device Problem Leak/Splash (1354)
Patient Problem Aortic Valve Insufficiency/ Regurgitation (4450)
Event Date 08/11/2022
Event Type  Injury  
Manufacturer Narrative
The manufacturing and material records for the perceval plus heart valve, model #pvf-m, s/n # (b)(4), as they pertain to the reported event, were retrieved and reviewed by the manufacturer¿s quality engineering.The results confirmed that this valve satisfied all material, visual, and performance standards required for a model #pvf-m perceval plus heart valve at the time of manufacture and release.The steady flow test review was also performed.The images demonstrate the acceptable opened and closed leaflet performance of the perceval pvf-m sn# (b)(4).No anomalies are observed during the open/close cycle.The valve therefore meets the acceptance criteria of the steady flow test inspection defined in dedicated procedure, the principal device function test at the time of release.
 
Event Description
The manufacturer was informed that perceval plus sutureless aortic heart valve, pvf-m was implanted through right lateral anterior mini-thoracotomy on (b)(6) 2022.After the cpb, in the control echo, a mild central leak was observed.Reportedly, the pump time was 55'.In the echo 12 hours after implantation, a moderate/severe central leak as well as a paravalvular leak was observed.As such, the valve was explanted on (b)(6) 2022 and an edwards carpentier size 21 was implanted instead in supraannular position.
 
Manufacturer Narrative
The device was received by manufacturer on 15 sep 2022.A follow up report will be provided upon completion on device investigation.
 
Manufacturer Narrative
The valve was returned to the manufacturer.After decontamination, the valve was visually inspected without observing macroscopic abnormalities and/or pre-existing defects according to specifications.The valve was stained with blood and the pericardium has an onset of dehydration, particularly evident on the edge of the free margin of the leaflets.The storage conditions before returning the product were probably not optimal: the free margins show the typical appearance and morphology due to a dehydration process that has altered the mechanical properties of the pericardium.For this reason, any further investigation (i.E.Hydrodynamic test) was considered not representative of the original conditions.As such, no further investigation could be performed.Based on the analysis performed, no pre-existing defects with the valve were identified.Review of the manufacturing data for the returned valve also confirmed that the valve satisfied all material, dimensional, and performance standards required for pvf-m at the time of manufacture and release.Based on the information available, edwards carpentier valve size 21 was ultimately implanted in the supra-annular position.Comparing the internal diameter indicated in the sizing table for edwards carpentier size 21 and aortic diameter for perceval plus size m, points at an oversizing as a possible root cause of the reported event.Should further information be received in the future, a follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL PLUS SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer (Section G)
CORCYM CANADA CORP.
5005 north fraser way
burnaby, bc
Manufacturer Contact
roberta lamberti
5005 north fraser way
burnaby, bc 
MDR Report Key15397511
MDR Text Key299665627
Report Number3004478276-2022-00184
Device Sequence Number1
Product Code LWR
UDI-Device Identifier00896208000801
UDI-Public(01)00896208000801(240)PVF-M(17)260416
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011/S013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 11/11/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberPVF-M
Device Catalogue NumberPVF-M
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 08/11/2022
Initial Date FDA Received09/10/2022
Supplement Dates Manufacturer Received09/15/2022
10/14/2022
Supplement Dates FDA Received10/11/2022
11/11/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/16/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-